Comments on: Generic clopidogrel: whiplash for the masses http://onthepharm.net/2006/09/generic-plavix-halted.html Life on the pharm Sat, 22 Nov 2008 00:20:31 +0000 http://wordpress.org/?v=2.6.3 By: JimL http://onthepharm.net/2006/09/generic-plavix-halted.html#comment-132598 JimL Mon, 09 Jul 2007 01:18:52 +0000 http://onthepharm.net/2006/09/generic-plavix-halted.html#comment-132598 Its really all about money. Never mine the patient who could use the cheaper generic. Its really all about money. Never mine the patient who could use
the cheaper generic.

]]> By: RJS http://onthepharm.net/2006/09/generic-plavix-halted.html#comment-6517 RJS Fri, 15 Dec 2006 22:28:59 +0000 http://onthepharm.net/2006/09/generic-plavix-halted.html#comment-6517 Yeah I posted about it <a href="http://onthepharm.net/2006/11/generic-clopidogrel-withdrawn.html" rel="nofollow">here</a>. Yeah I posted about it here.

]]> By: Douglas Anderson http://onthepharm.net/2006/09/generic-plavix-halted.html#comment-6513 Douglas Anderson Fri, 15 Dec 2006 21:27:39 +0000 http://onthepharm.net/2006/09/generic-plavix-halted.html#comment-6513 It looks like generic Plavix is going to be on hold for a while. Preliminary Injunction Against Apotex Upheld On Appeal 10 Dec 2006 Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) and Bristol-Myers Squibb Company (New York: NYSE: BMY) (the "companies") announced today that the United States Court of Appeals for the Federal Circuit has upheld the August 31, 2006 preliminary injunction issued by the United States District Court for the Southern District of New York. The injunction ordered Apotex to halt its sales of a generic version of clopidogrel bisulfate that competes with PLAVIX® pending the District Court's decision in the trial on the merits. As a result of the decision of the Court of Appeals, the preliminary injunction remains in place. The companies believe that the Apotex generic product infringes their intellectual property rights, which they continue to vigorously defend in the pending patent litigation. Trial on the merits is currently scheduled to begin on January 22, 2007. It looks like generic Plavix is going to be on hold for a while.

Preliminary Injunction Against Apotex Upheld On Appeal
10 Dec 2006

Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) and Bristol-Myers Squibb Company (New York: NYSE: BMY) (the "companies") announced today that the United States Court of Appeals for the Federal Circuit has upheld the August 31, 2006 preliminary injunction issued by the United States District Court for the Southern District of New York. The injunction ordered Apotex to halt its sales of a generic version of clopidogrel bisulfate that competes with PLAVIX® pending the District Court's decision in the trial on the merits. As a result of the decision of the Court of Appeals, the preliminary injunction remains in place.

The companies believe that the Apotex generic product infringes their intellectual property rights, which they continue to vigorously defend in the pending patent litigation. Trial on the merits is currently scheduled to begin on January 22, 2007.

]]> By: Goodbye, generic Plavix (for real) :: OnThePharm http://onthepharm.net/2006/09/generic-plavix-halted.html#comment-5513 Goodbye, generic Plavix (for real) :: OnThePharm Fri, 01 Dec 2006 02:53:24 +0000 http://onthepharm.net/2006/09/generic-plavix-halted.html#comment-5513 [...] So it looks like at the end of next week, we’re going to run out of generic Plavix. I’ve not followed the business drama of Big Pharma in a little while because I find it dull, so I have no commentary on the outcome of the lawsuit, which I presume has been settled in S-A and BMS’s favor. Apotex had a good run while it lasted. I mentioned in September that we were warned that this might happen. [...] [...] So it looks like at the end of next week, we're going to run out of generic Plavix. I've not followed the business drama of Big Pharma in a little while because I find it dull, so I have no commentary on the outcome of the lawsuit, which I presume has been settled in S-A and BMS's favor. Apotex had a good run while it lasted. I mentioned in September that we were warned that this might happen. [...]

]]>